Results 101 to 110 of about 22,089 (224)

Fatal Coxsackievirus A-16 Pneumonitis in Adult

, 2007
Coxsackievirus A-16 (CVA-16) is the agent of hand, foot, and mouth disease in children. We report a case of fatal pneumonitis in an adult due to a CVA-16 strain with a low (78.6%) rate of sequence homology with the reference strain.
Pierre Tattevin, Jean-Jacques Chomel, Nicolas Lévêque, François Legay, Rémi Thomas, Arnaud Gacouin, Julien Bouet   +6 more
core   +1 more source

Enterovirus genotype diversity with emergence of coxsackievirus A2 circulating in pediatric patients with acute gastroenteritis in Thailand, 2019–2022

Frontiers in Microbiology
IntroductionEnteroviruses (EVs) are recognized as potential causative agents of acute gastroenteritis (AGE) in children worldwide. This study aimed to investigate the epidemiology and molecular characteristics of EV infection in children admitted to ...
Zhenfeng Xie, Zhenfeng Xie, Pattara Khamrin, Pattara Khamrin, Nutthawadee Jampanil, Arpaporn Yodmeeklin, Arpaporn Yodmeeklin, Nuthapong Ukarapol, Nuthapong Ukarapol, Niwat Maneekarn, Niwat Maneekarn, Kattareeya Kumthip, Kattareeya Kumthip   +12 more
doaj   +1 more source

Hand, Foot and Mouth Disease Caused by Coxsackievirus A6, Thailand, 2012

, 2013
In Thailand, hand, foot, and mouth disease (HFMD) is usually caused by enterovirus 71 or coxsackievirus A16. To determine the cause of a large outbreak of HFMD in Thailand during June–August 2012, we examined patient specimens.
Jiratchaya Puenpa, Sumeth Korkong, Yong Poovorawan, Piyada Linsuwanon, Preyaporn Vichaiwattana, Thaweesak Chieochansin, Apiradee Theamboonlers, Siwanat Thongkomplew   +7 more
core   +1 more source

Applications of coxsackievirus A21 in oncology

Oncolytic Virotherapy, 2014
The clinical management of cancer continues to be dominated by macroscopic surgical resection, radiotherapy, and cytotoxic drugs. The major challenge facing oncology is to achieve more selective, less toxic and effective methods of targeting disseminated tumors, a challenge oncolytic virotherapy may be well-placed to meet.
Bradley, S, Jakes, A, Harrington, K, Pandha, H, Melcher, A, Errington-Mais, F   +5 more
openaire   +5 more sources

Identification of Drug Repurposing Candidates for Coxsackievirus B3 Infection in iPSC-Derived Brain-like Endothelial Cells

The enterovirus Coxsackievirus B3 causes a range of serious health problems, including aseptic meningitis, myocarditis, and pancreatitis. Currently, Coxsackievirus B3 has no targeted antiviral treatments or vaccines, leaving supportive care as the ...
Ali S. Imami, Brandon J. Kim, Robert E. McCullumsmith, Jacob F. Wood, Isaac T. Schiefer, John M. Vergis, Jon J. Sin, William G. Ryan   +7 more
core   +1 more source

A Point Mutation in VP1 of Coxsackievirus B4 Alters Antigenicity

, 2000
While coxsackievirus infections have been linked to several autoimmune diseases, very little is known about the immunogenicity of the coxsackieviruses. Using two genetically related variants of coxsackievirus B4, CB4-P and CB4-V, the relationship between
Ramsingh, Arlene I., Halim, Sadia
core   +1 more source

Acute hemorrhagic conjunctivitis: anti-coxsackievirus A24 variant secretory immunoglobulin A in acute and convalescent tear

, 2015
Marlyn P Langford, Edwin A Anders, Maxwell A BurchDepartment of Ophthalmology, Louisiana State University Health Sciences Center, Shreveport, LA, USA Purpose: The purpose of this paper is to present the clinical course of a laboratory-acquired case of ...
Burch MA, Anders EA, Langford MP
core  

Nitric oxide and murine coxsackievirus B3 myocarditis: Aggravation of myocarditis by inhibition of nitric oxide synthase

, 1996
Objectives. This study sought to investigate the effects of nitric oxide inhibition in a murine model of coxsackievirus B3 myocarditis.Background. Little is known about the contribution of nitric oxide to the pathophysiology of myocarditis.Methods ...
Hiroshi Ochiai, Shiraki, Kimiyasu, Hiraoka, Yuji, Nakamura, Michiyo, Ochiai, Hiroshi, Kimiyasu Shiraki, Michiyo Nakamura, Masahiko Kurokawa, Takada, Hitoshi, Kishimoto, Chiharu, Kurokawa, Masahiko, Yuji Hiraoka, Hitoshi Takada, Chiharu Kishimoto   +13 more
core   +1 more source

Ivabradine Treatment Reduces Cardiomyocyte Apoptosis in a Murine Model of Chronic Viral Myocarditis

Frontiers in Pharmacology, 2018
This study was designed to explore the effects of ivabradine on cardiomyocyte apoptosis in a murine model of chronic viral myocarditis (CVMC). Mice were inoculated intraperitoneally with Coxsackievirus B3 at days 1, 14, and 28, respectively.
Ge Li-Sha, Liu Li, Liu Li, Zhou De-Pu, Shi Zhe-Wei, Gu Xiaohong, Chen Guang-Yi, Li Jia, Lin Jia-Feng, Chu Maoping, Li Yue-Chun   +10 more
doaj   +1 more source

Control of in vitro and in vivo spread of coxsackievirus B4 infection by sensitized spleen cells and antibody

, 1978
The effects of antibody and immune spleen cells of mice on the spread of coxsackievirus B4 in monkey kidney tissue cultures and mice were investigated.
H. O. Tandon, Mathur, Asha, Chaturvedi, U. C., U. C. Chaturvedi, A. Mathur, Tandon, H. O.   +5 more
core   +1 more source